Hempel, T., Elez, K., Krüger, N., Raich, L., Shrimp, J. H., Danov, O., Jonigk, D., Braun, A., Shen, M., Hall, M. D., Pöhlmann,
S., Hoffmann, M., & Noé, F. (2021). Synergistic inhibition of SARS-CoV-2 cell entry
by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties. Chemical Science, 12(38), 12600-12609. doi:10.1039/d1sc01494c.